Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Infectious Diseases Molecular Diagnostics Market Growth (Status and Outlook) 2022-2028

  • LP 4933351
  • 104 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Infectious Diseases Molecular Diagnostics will have significant change from previous year. According to our (LP Information) latest study, the global Infectious Diseases Molecular Diagnostics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Infectious Diseases Molecular Diagnostics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Infectious Diseases Molecular Diagnostics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Infectious Diseases Molecular Diagnostics market, reaching US$ million by the year 2028. As for the Europe Infectious Diseases Molecular Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Infectious Diseases Molecular Diagnostics players cover Roche, Qiagen, Illumina, and Abbott, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Diseases Molecular Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Polymerase Chain Reaction PCR

Molecular Hybridization

Biochip

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospital

Third-party Testing Agency

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Roche

Qiagen

Illumina

Abbott

Hologic

BioMerieux

Danaher (Cepheid)

Myriad Genetics

DAAN Gene

Agilent

Genomic Health

BD

Foundation Medicine

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Infectious Diseases Molecular Diagnostics Market Size 2017-2028

2.1.2 Infectious Diseases Molecular Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Infectious Diseases Molecular Diagnostics Segment by Type

2.2.1 Polymerase Chain Reaction PCR

2.2.2 Molecular Hybridization

2.2.3 Biochip

2.2.4 Other

2.3 Infectious Diseases Molecular Diagnostics Market Size by Type

2.3.1 Infectious Diseases Molecular Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2017-2022)

2.4 Infectious Diseases Molecular Diagnostics Segment by Application

2.4.1 Hospital

2.4.2 Third-party Testing Agency

2.4.3 Other

2.5 Infectious Diseases Molecular Diagnostics Market Size by Application

2.5.1 Infectious Diseases Molecular Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2017-2022)

3 Infectious Diseases Molecular Diagnostics Market Size by Player

3.1 Infectious Diseases Molecular Diagnostics Market Size Market Share by Players

3.1.1 Global Infectious Diseases Molecular Diagnostics Revenue by Players (2020-2022)

3.1.2 Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Players (2020-2022)

3.2 Global Infectious Diseases Molecular Diagnostics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Infectious Diseases Molecular Diagnostics by Regions

4.1 Infectious Diseases Molecular Diagnostics Market Size by Regions (2017-2022)

4.2 Americas Infectious Diseases Molecular Diagnostics Market Size Growth (2017-2022)

4.3 APAC Infectious Diseases Molecular Diagnostics Market Size Growth (2017-2022)

4.4 Europe Infectious Diseases Molecular Diagnostics Market Size Growth (2017-2022)

4.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022)

5.2 Americas Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022)

5.3 Americas Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Infectious Diseases Molecular Diagnostics Market Size by Region (2017-2022)

6.2 APAC Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022)

6.3 APAC Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Infectious Diseases Molecular Diagnostics by Country (2017-2022)

7.2 Europe Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022)

7.3 Europe Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Infectious Diseases Molecular Diagnostics by Region (2017-2022)

8.2 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022)

8.3 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Infectious Diseases Molecular Diagnostics Market Forecast

10.1 Global Infectious Diseases Molecular Diagnostics Forecast by Regions (2023-2028)

10.1.1 Global Infectious Diseases Molecular Diagnostics Forecast by Regions (2023-2028)

10.1.2 Americas Infectious Diseases Molecular Diagnostics Forecast

10.1.3 APAC Infectious Diseases Molecular Diagnostics Forecast

10.1.4 Europe Infectious Diseases Molecular Diagnostics Forecast

10.1.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Forecast

10.2 Americas Infectious Diseases Molecular Diagnostics Forecast by Country (2023-2028)

10.2.1 United States Infectious Diseases Molecular Diagnostics Market Forecast

10.2.2 Canada Infectious Diseases Molecular Diagnostics Market Forecast

10.2.3 Mexico Infectious Diseases Molecular Diagnostics Market Forecast

10.2.4 Brazil Infectious Diseases Molecular Diagnostics Market Forecast

10.3 APAC Infectious Diseases Molecular Diagnostics Forecast by Region (2023-2028)

10.3.1 China Infectious Diseases Molecular Diagnostics Market Forecast

10.3.2 Japan Infectious Diseases Molecular Diagnostics Market Forecast

10.3.3 Korea Infectious Diseases Molecular Diagnostics Market Forecast

10.3.4 Southeast Asia Infectious Diseases Molecular Diagnostics Market Forecast

10.3.5 India Infectious Diseases Molecular Diagnostics Market Forecast

10.3.6 Australia Infectious Diseases Molecular Diagnostics Market Forecast

10.4 Europe Infectious Diseases Molecular Diagnostics Forecast by Country (2023-2028)

10.4.1 Germany Infectious Diseases Molecular Diagnostics Market Forecast

10.4.2 France Infectious Diseases Molecular Diagnostics Market Forecast

10.4.3 UK Infectious Diseases Molecular Diagnostics Market Forecast

10.4.4 Italy Infectious Diseases Molecular Diagnostics Market Forecast

10.4.5 Russia Infectious Diseases Molecular Diagnostics Market Forecast

10.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Forecast by Region (2023-2028)

10.5.1 Egypt Infectious Diseases Molecular Diagnostics Market Forecast

10.5.2 South Africa Infectious Diseases Molecular Diagnostics Market Forecast

10.5.3 Israel Infectious Diseases Molecular Diagnostics Market Forecast

10.5.4 Turkey Infectious Diseases Molecular Diagnostics Market Forecast

10.5.5 GCC Countries Infectious Diseases Molecular Diagnostics Market Forecast

10.6 Global Infectious Diseases Molecular Diagnostics Forecast by Type (2023-2028)

10.7 Global Infectious Diseases Molecular Diagnostics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Roche

11.1.1 Roche Company Information

11.1.2 Roche Infectious Diseases Molecular Diagnostics Product Offered

11.1.3 Roche Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Roche Main Business Overview

11.1.5 Roche Latest Developments

11.2 Qiagen

11.2.1 Qiagen Company Information

11.2.2 Qiagen Infectious Diseases Molecular Diagnostics Product Offered

11.2.3 Qiagen Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Qiagen Main Business Overview

11.2.5 Qiagen Latest Developments

11.3 Illumina

11.3.1 Illumina Company Information

11.3.2 Illumina Infectious Diseases Molecular Diagnostics Product Offered

11.3.3 Illumina Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Illumina Main Business Overview

11.3.5 Illumina Latest Developments

11.4 Abbott

11.4.1 Abbott Company Information

11.4.2 Abbott Infectious Diseases Molecular Diagnostics Product Offered

11.4.3 Abbott Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Abbott Main Business Overview

11.4.5 Abbott Latest Developments

11.5 Hologic

11.5.1 Hologic Company Information

11.5.2 Hologic Infectious Diseases Molecular Diagnostics Product Offered

11.5.3 Hologic Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Hologic Main Business Overview

11.5.5 Hologic Latest Developments

11.6 BioMerieux

11.6.1 BioMerieux Company Information

11.6.2 BioMerieux Infectious Diseases Molecular Diagnostics Product Offered

11.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 BioMerieux Main Business Overview

11.6.5 BioMerieux Latest Developments

11.7 Danaher (Cepheid)

11.7.1 Danaher (Cepheid) Company Information

11.7.2 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Offered

11.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Danaher (Cepheid) Main Business Overview

11.7.5 Danaher (Cepheid) Latest Developments

11.8 Myriad Genetics

11.8.1 Myriad Genetics Company Information

11.8.2 Myriad Genetics Infectious Diseases Molecular Diagnostics Product Offered

11.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Myriad Genetics Main Business Overview

11.8.5 Myriad Genetics Latest Developments

11.9 DAAN Gene

11.9.1 DAAN Gene Company Information

11.9.2 DAAN Gene Infectious Diseases Molecular Diagnostics Product Offered

11.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 DAAN Gene Main Business Overview

11.9.5 DAAN Gene Latest Developments

11.10 Agilent

11.10.1 Agilent Company Information

11.10.2 Agilent Infectious Diseases Molecular Diagnostics Product Offered

11.10.3 Agilent Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Agilent Main Business Overview

11.10.5 Agilent Latest Developments

11.11 Genomic Health

11.11.1 Genomic Health Company Information

11.11.2 Genomic Health Infectious Diseases Molecular Diagnostics Product Offered

11.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Genomic Health Main Business Overview

11.11.5 Genomic Health Latest Developments

11.12 BD

11.12.1 BD Company Information

11.12.2 BD Infectious Diseases Molecular Diagnostics Product Offered

11.12.3 BD Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 BD Main Business Overview

11.12.5 BD Latest Developments

11.13 Foundation Medicine

11.13.1 Foundation Medicine Company Information

11.13.2 Foundation Medicine Infectious Diseases Molecular Diagnostics Product Offered

11.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Foundation Medicine Main Business Overview

11.13.5 Foundation Medicine Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Infectious Diseases Molecular Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Polymerase Chain Reaction PCR

Table 3. Major Players of Molecular Hybridization

Table 4. Major Players of Biochip

Table 5. Major Players of Other

Table 6. Infectious Diseases Molecular Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2017-2022)

Table 9. Infectious Diseases Molecular Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2017-2022)

Table 12. Global Infectious Diseases Molecular Diagnostics Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Player (2020-2022)

Table 14. Infectious Diseases Molecular Diagnostics Key Players Head office and Products Offered

Table 15. Infectious Diseases Molecular Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Infectious Diseases Molecular Diagnostics Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Regions (2017-2022)

Table 20. Americas Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Infectious Diseases Molecular Diagnostics Market Size Market Share by Country (2017-2022)

Table 22. Americas Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2017-2022)

Table 24. Americas Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2017-2022)

Table 26. APAC Infectious Diseases Molecular Diagnostics Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Region (2017-2022)

Table 28. APAC Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2017-2022)

Table 30. APAC Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2017-2022)

Table 32. Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Country (2017-2022)

Table 34. Europe Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2017-2022)

Table 36. Europe Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Infectious Diseases Molecular Diagnostics

Table 45. Key Market Challenges & Risks of Infectious Diseases Molecular Diagnostics

Table 46. Key Industry Trends of Infectious Diseases Molecular Diagnostics

Table 47. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Infectious Diseases Molecular Diagnostics Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Infectious Diseases Molecular Diagnostics Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Infectious Diseases Molecular Diagnostics Market Size Market Share Forecast by Application (2023-2028)

Table 53. Roche Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors

Table 54. Roche Infectious Diseases Molecular Diagnostics Product Offered

Table 55. Roche Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Roche Main Business

Table 57. Roche Latest Developments

Table 58. Qiagen Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors

Table 59. Qiagen Infectious Diseases Molecular Diagnostics Product Offered

Table 60. Qiagen Main Business

Table 61. Qiagen Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Qiagen Latest Developments

Table 63. Illumina Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors

Table 64. Illumina Infectious Diseases Molecular Diagnostics Product Offered

Table 65. Illumina Main Business

Table 66. Illumina Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Illumina Latest Developments

Table 68. Abbott Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors

Table 69. Abbott Infectious Diseases Molecular Diagnostics Product Offered

Table 70. Abbott Main Business

Table 71. Abbott Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Abbott Latest Developments

Table 73. Hologic Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors

Table 74. Hologic Infectious Diseases Molecular Diagnostics Product Offered

Table 75. Hologic Main Business

Table 76. Hologic Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Hologic Latest Developments

Table 78. BioMerieux Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors

Table 79. BioMerieux Infectious Diseases Molecular Diagnostics Product Offered

Table 80. BioMerieux Main Business

Table 81. BioMerieux Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. BioMerieux Latest Developments

Table 83. Danaher (Cepheid) Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors

Table 84. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Offered

Table 85. Danaher (Cepheid) Main Business

Table 86. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Danaher (Cepheid) Latest Developments

Table 88. Myriad Genetics Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors

Table 89. Myriad Genetics Infectious Diseases Molecular Diagnostics Product Offered

Table 90. Myriad Genetics Main Business

Table 91. Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Myriad Genetics Latest Developments

Table 93. DAAN Gene Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors

Table 94. DAAN Gene Infectious Diseases Molecular Diagnostics Product Offered

Table 95. DAAN Gene Main Business

Table 96. DAAN Gene Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. DAAN Gene Latest Developments

Table 98. Agilent Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors

Table 99. Agilent Infectious Diseases Molecular Diagnostics Product Offered

Table 100. Agilent Main Business

Table 101. Agilent Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Agilent Latest Developments

Table 103. Genomic Health Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors

Table 104. Genomic Health Infectious Diseases Molecular Diagnostics Product Offered

Table 105. Genomic Health Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Genomic Health Main Business

Table 107. Genomic Health Latest Developments

Table 108. BD Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors

Table 109. BD Infectious Diseases Molecular Diagnostics Product Offered

Table 110. BD Main Business

Table 111. BD Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. BD Latest Developments

Table 113. Foundation Medicine Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors

Table 114. Foundation Medicine Infectious Diseases Molecular Diagnostics Product Offered

Table 115. Foundation Medicine Main Business

Table 116. Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. Foundation Medicine Latest Developments

List of Figures

Figure 1. Infectious Diseases Molecular Diagnostics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Infectious Diseases Molecular Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Type in 2021

Figure 7. Infectious Diseases Molecular Diagnostics in Hospital

Figure 8. Global Infectious Diseases Molecular Diagnostics Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Infectious Diseases Molecular Diagnostics in Third-party Testing Agency

Figure 10. Global Infectious Diseases Molecular Diagnostics Market: Third-party Testing Agency (2017-2022) & ($ Millions)

Figure 11. Infectious Diseases Molecular Diagnostics in Other

Figure 12. Global Infectious Diseases Molecular Diagnostics Market: Other (2017-2022) & ($ Millions)

Figure 13. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Application in 2021

Figure 14. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Player in 2021

Figure 15. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Infectious Diseases Molecular Diagnostics Market Size 2017-2022 ($ Millions)

Figure 17. APAC Infectious Diseases Molecular Diagnostics Market Size 2017-2022 ($ Millions)

Figure 18. Europe Infectious Diseases Molecular Diagnostics Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size 2017-2022 ($ Millions)

Figure 20. Americas Infectious Diseases Molecular Diagnostics Value Market Share by Country in 2021

Figure 21. Americas Infectious Diseases Molecular Diagnostics Consumption Market Share by Type in 2021

Figure 22. Americas Infectious Diseases Molecular Diagnostics Market Size Market Share by Application in 2021

Figure 23. United States Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Region in 2021

Figure 28. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Application in 2021

Figure 29. China Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Country in 2021

Figure 36. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Type in 2021

Figure 37. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Application in 2021

Figure 38. Germany Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Application in 2021

Figure 46. Egypt Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Infectious Diseases Molecular Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 52. APAC Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 53. Europe Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 55. United States Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 56. Canada Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 59. China Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 60. Japan Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 61. Korea Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 63. India Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 64. Australia Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 65. Germany Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 66. France Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 67. UK Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 68. Italy Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 69. Russia Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 70. Spain Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 73. Israel Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Infectious Diseases Molecular Diagnostics Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450